Abstract
Desmoid tumor is a soft tissue neoplasm that can occur in children as well as adults. Formally classified as an intermediate-grade neoplasm, it is known to have a locally invasive growth that can lead to severe and sometimes life-threatening problems. The historical standards of therapy for desmoid tumor center on surgical resection, with or without radiation therapy. However, depending on the site or size of the disease, surgical resection may substantially compromise form or function, making its use especially problematic in children who may be physically and psychologically immature. Further, there is some evidence that radiation is less effective against desmoid tumor in children, as compared to adults with this disease. As such, the treatment of a child with desmoid tumor may present unique problems. In this chapter, we review the pathology, biology, clinical presentation, and treatment of children with desmoid tumor as we highlight the similarities and differences from desmoid tumor in adults.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn JM, Yoon HK, Suh YL et al (2000) Infantile fibromatosis in childhood: findings on MR imaging and pathologic correlation. Clin Radiol 55(1):19–24
Alebouyeh M, Moussavi F, Tabari AK, Vossough P (2005) Aggressive intra-abdominal fibromatosis in children and response to chemotherapy. Pediatr Hematol Oncol 22(6):447–451
Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151(2):329–334
Amary MF, Pauwels P, Meulemans E et al (2007) Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol 31(9):1299–1309
Ayala AG, Ro JY, Goepfert H, Cangir A, Khorsand J, Flake G (1986) Desmoid fibromatosis: a clinicopathologic study of 25 children. Semin Diagn Pathol 3(2):138–150
Balamuth N, Womer R (2008) Successful treatment of pediatric desmoid tumors using hydroxyurea. Connective Tissue Oncology Society Meeting, London
Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA (1999) Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17(1):158–167
Benson JR, Mokbel K, Baum M (1994) Management of desmoid tumours including a case report of toremifene. Ann Oncol 5(2):173–177
Bonvalot S, Eldweny H, Haddad V et al (2008) Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 34(4):462–468
Buitendijk S, van de Ven CP, Dumans TG et al (2005) Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature. Cancer 104(5):1090–1099
Carlson JW, Fletcher CD (2007) Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 51(4):509–514
Clark SK, Pack K, Pritchard J, Hodgson SV (1997) Familial adenomatous polyposis presenting with childhood desmoids. Lancet 349(9050):471–472
Clark SK, Smith TG, Katz DE, Reznek RH, Phillips RK (1998) Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg 85(7):970–973
Coffin CM, Dehner LP, O’Shea PA (eds) (1997) Pediatic soft tissue tumors. Williams & Wilkins, Baltimore, pp 133–159
Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I (2009) Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer 45(17):2930–2934
De Wever I, Dal Cin P, Fletcher CD et al (2000) Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. Chromosomes and morphology. Mod Pathol 13(10):1080–1085
Delepine N, Delepine G, Desbois JC, Mathe G, Legmann F (1987) Reponse objective du fibrome desmoide a la chimiotherapie (Objective response of desmoid fibroma to chemotherapy). Biomed Pharmacother 41(3):146–148
Dormans JP, Spiegel D, Meyer J et al (2001) Fibromatoses in childhood: the desmoid/fibromatosis complex. Med Pediatr Oncol 37(2):126–131
Eich GF, Hoeffel JC, Tschappeler H, Gassner I, Willi UV (1998) Fibrous tumours in children: imaging features of a heterogeneous group of disorders. Pediatr Radiol 28(7):500–509
Enzinger FM, Weiss SW (1983) Soft tissue tumors, 1st edn. CV Mosby, St. Louis
Faulkner LB, Hajdu SI, Kher U et al (1995) Pediatric desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol 13(11):2813–2818
Fiore M, Rimareix F, Mariani L et al (2009) Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 16(9):2587–2593
Gansar GF, Krementz ET (1988) Desmoid tumors: experience with new modes of therapy. South Med J 81(6):794–796
Gebert C, Hardes J, Kersting C et al (2007) Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis. Histopathology 50(4):491–497
Gega M, Yanagi H, Yoshikawa R et al (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24(1):102–105
Giarola M, Wells D, Mondini P et al (1998) Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 78(5):582–587
Goepfert H, Cangir A, Ayala AG, Eftekhari F (1982) Chemotherapy of locally aggressive head and neck tumors in the pediatric age group. Desmoid fibromatosis and nasopharyngeal angiofibroma. Am J Surg 144(4):437–444
Goldblum J, Fletcher J (2002) Desmoid-type fibromatosis. International Agency for Research on Cancer Press, Lyon
Gurbuz AK, Giardiello FM, Petersen GM et al (1994) Desmoid tumours in familial adenomatous polyposis. Gut 35(3):377–381
Halata MS, Miller J, Stone RK (1989) Gardner syndrome. Early presentation with a desmoid tumor. Discovery of multiple colonic polyps. Clin Pediatr (Phila) 28(11):538–540
Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G (2004) High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100(3):612–620
Heinrich MC, McArthur GA, Demetri GD et al (2006) Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24(7):1195–1203
Huang PW, Tzen CY (2010) Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases. Pathology 42(2):147–150
Humar A, Chou S, Carpenter B (1993) Fibromatosis in infancy and childhood: the spectrum. J Pediatr Surg 28(11):1446–1450
Ishizuka M, Hatori M, Dohi O et al (2006) Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med 210(3):189–198
Jabbari S, Andolino D, Weinberg V et al (2009) Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. Int J Radiat Oncol Biol Phys 75(1):177–182
Jelinek JA, Stelzer KJ, Conrad E et al (2001) The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 50(1):121–125
Kamath SS, Parsons JT, Marcus RB, Zlotecki RA, Scarborough MT(1996) Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 6:325–328
Kiel KD, Suit HD (1984) Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer 54(10):2051–2055
Kingston CA, Owens CM, Jeanes A, Malone M (2002) Imaging of desmoid fibromatosis in pediatric patients. Am J Roentgenol 178(1):191–199
Lackner H, Urban C, Kerbl R, Schwinger W, Beham A (1997) Noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer 80(2):334–340
Latchford AR, Sturt NJ, Neale K, Rogers PA, Phillips RK (2006) A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 93(10):1258–1264
Lazar AJ, Tuvin D, Hajibashi S et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173(5):1518–1527
Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E (2006) Aggressive fibromatosis: MRI features with pathologic correlation. Am J Roentgenol 186(1):247–254
Leithner A, Schnack B, Katterschafka T et al (2000) Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol 73(1):21–25
Lev D, Kotilingam D, Wei C et al (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25(13):1785–1791
Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF (1999) The enigma of desmoid tumors. Ann Surg 229(6):866–872; discussion 872–873
Lim CL, Walker MJ, Mehta RR, Das Gupta TK (1986) Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 22(5):583–587
McCarville MB, Hoffer FA, Adelman CS, Khoury JD, Li C, Skapek SX (2007) MRI and biologic behavior of desmoid tumors in children. Am J Roentgenol 189(3):633–640
McDougall A, McGarrity G (1979) Extra-abdominal desmoid tumours. J Bone Joint Surg Br 61-B(3):373–377
Meazza C, Bisogno G, Gronchi A et al (2010) Aggressive fibromatosis in children and adolescents: the Italian experience. Cancer 116(1):233–240
Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF (1999) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86(10):2045–2052
Merchant TE, Nguyen D, Walter AW, Pappo AS, Kun LE, Rao BN (2000) Long-term results with radiation therapy for pediatric desmoid tumors. Int J Radiat Oncol Biol Phys 47(5):1267–1271
Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1993) Coexistence of somatic and germ- line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 53(21):5079–5082
Mukherjee A, Malcolm A, de la Hunt M, Neal DE (1995) Pelvic fibromatosis (desmoid)—treatment with steroids and tamoxifen. Br J Urol 75(4):559–560
Muller E, Castagnaro M, Yandel DW, Wolfe HJ, Alman BA (1996) Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and p53 in palmar and aggressive fibromatosis. Diagn Mol Pathol 5(3):194–200
Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, Dekkers OM, Hogendoorn PC, Vasen HF (2010) A nation-wide study comparing sporadic and familial adenomatous polyposis (FAP) related desmoid-type fibromatoses. Int J Cancer doi:10.1002/ijc.25664
Parham DM (1996) Pediatric neoplasia: morphology and biology. Lippincott-Raven, Philadelphia, pp 230–232
Patel SR, Evans HL, Benjamin RS (1993) Combination chemotherapy in adult desmoid tumors. Cancer 72(11):3244–3247
Picariello L, Fiorelli G, Benvenuti S et al (1997) In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells. Anticancer Res 17(3C):2099–2104
Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF (1989) The desmoid tumor. Not a benign disease. Arch Surg 124(2):191
Ramirez RN, Otsuka NY, Apel DM, Bowen RE (2009) Desmoid tumor in the pediatric population: a report of two cases. J Pediatr Orthop B 18(3):141–144
Raney B, Evans A, Granowetter L, Schnaufer L, Uri A, Littman P (1987) Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics 79(3):394–398
Rao BN, Horowitz ME, Parham DM et al (1987) Challenges in the treatment of childhood fibromatosis. Arch Surg 122(11):1296–1298
Reich S, Overberg-Schmidt US, Buhrer C, Henze G (1999) Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J Clin Oncol 17(3):1086
Reitamo JJ (1983) The desmoid tumor. IV. Choice of treatment, results, and complications. Arch Surg 118(11):1318–1322
Reitamo JJ, Scheinin TM, Hayry P (1986) The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 151(2):230–237
Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC (1984) Extra-abdominal desmoid tumors. J Bone Joint Surg Am 66(9):1369–1374
Romero JA, Kim EE, Kim CG, Chung WK, Isiklar I (1995) Different biologic features of desmoid tumors in adult and juvenile patients: MR demonstration. J Comput Assist Tomogr 19(5):782–787
Santos GA, Cunha IW, Rocha RM et al (2010) Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options. Biosci Trends 4(1):25–30
Sharma A, Ngan BY, Sandor GK, Campisi P, Forte V (2008) Pediatric aggressive fibromatosis of the head and neck: a 20-year retrospective review. J Pediatr Surg 43(9):1596–1604
Sherman NE, Romsdahl M, Evans H, Zagars G, Oswald MJ (1990) Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys 19(1):37–40
Skapek SX, Hawk BJ, Hoffer FA et al (1998) Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol 16(9):3021–3027
Skapek SX, Ferguson WS, Granowetter L et al (2007) Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol 25(5):501–506
Sorensen A, Keller J, Nielsen OS, Jensen OM (2002) Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand 73(2):213–219
Spear MA, Jennings LC, Mankin HJ et al (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40(3):637–645
Spiegel DA, Dormans JP, Meyer JS et al (1999) Aggressive fibromatosis from infancy to adolescence. J Pediatr Orthop 19(6):776–784
Stein R (1977) Chemotherapeutic response in fibromatosis of the neck. J Pediatr 90(3):482–483
Stockdale AD, Cassoni AM, Coe MA et al (1988) Radiotherapy and conservative surgery in the management of musculo-aponeurotic fibromatosis. Int J Radiat Oncol Biol Phys 15(4):851–857
Tejpar S, Nollet F, Li C et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18(47):6615–6620
Thway K, Gibson S, Ramsay A, Sebire NJ (2009) Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases. Pediatr Dev Pathol 12(4):292–296
Wehl G, Rossler J, Otten JE et al (2004) Response of progressive fibromatosis to therapy with liposomal doxorubicin. Onkologie 27(6):552–556
Wehrli BM, Weiss SW, Yandow S, Coffin CM (2001) Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol 25(5):645–651
Weiss AJ, Lackman RD (1989) Low-dose chemotherapy of desmoid tumors. Cancer 64(6):1192–1194
Weiss SW, Goldblum JR (eds) (2008) Enzinger and Weiss’s soft tissue tumors. Mosby, Philadelphia, pp 275–279
Weyl Ben Arush M, Meller I, Moses M et al (1998) Multifocal desmoid tumor in childhood: report of two cases and review of the literature. Pediatr Hematol Oncol 15(1):55–61
Wilcken N, Tattersall MH (1991) Endocrine therapy for desmoid tumors. Cancer 68(6):1384–1388
Woo SY, HC Doku HD, Chung KD (1984) Fibromatosis of the mandible and mitral valve responding to systemic chemotherapy. Proc Am Soc Clin Oncol 3:78–79
Zelefsky MJ, Harrison LB, Shiu MH, Armstrong JG, Hajdu SI, Brennan MF (1991) Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors. Cancer 67(2):380–384
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Weiss, A.R., Montag, A., Skapek, S.X. (2012). Desmoid Tumor in Children and Adolescents: The Influence of Age. In: Litchman, C. (eds) Desmoid Tumors. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1685-8_11
Download citation
DOI: https://doi.org/10.1007/978-94-007-1685-8_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1684-1
Online ISBN: 978-94-007-1685-8
eBook Packages: MedicineMedicine (R0)